ASX Health Stocks: Oncosil advances pancreatic cancer device to Greece, its third potential market in Europe
Oncosil says first two patient treatments using OncoSil device happened in Greece Nova Eye says Medicare reimbursement decision in the US delayed from December to [more…]
There’s real scale potential to First Lithium’s ‘Goulamina-like’ Blakala prospect
The main pegmatite at First Lithium’s Blakala lithium prospect now stretches out over 1km of strike This remains open to the north, south and at [more…]
The Secret Broker: Lessons from Jesse Livermore on having the courage to live large
After 35 years of stockbroking for some of the biggest houses and investors in Australia and the UK, the Secret Broker is regaling Stockhead readers [more…]
Future Battery Minerals targeting a maiden lithium resource post RC drilling in Nevada
Future Battery Minerals has commenced RC drilling at its Nevada Lithium project with the aim of rapidly delineating a maiden mineral resource Drilling will target [more…]
Top 10 at 11: Not a lot of early movement, despite commodities swinging harder than a sleazy uncle
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live [more…]
Market Highlights: AI stocks up as Google unveils ChatGPT’s rival Gemini, and 5 ASX small caps to watch
ASX to open lower on Friday despite tech-led Wall Street rally Alphabet traded 5pc higher after the rollout of Gemini, its new AI tool We [more…]
Vulcan eyes green financing pathway after positive ESG report for zero carbon lithium project
Environmental and Social Impact Assessment complete for Vulcan Energy Resources’ Zero Carbon Lithium project in Germany The project is to produce lithium from Europe, for [more…]
BORDEAUX-HO-HO: Sorry kids, these quality French reds are top of the Xmas shopping list
You don’t have to be a Macquarie banker to place a bottle or two of Bordeaux on your Christmas table. Knowing where to source good [more…]
PETER STRACHAN: Where is the silver lining?
Peter Strachan is a capital markets veteran, resources analyst and lover of the oil and gas game. The brains behind the popular weekly StockAnalysis investment [more…]
Huge IPO interest and not lithium? LTR Pharma could be the next big thing on the ASX
With its innovative erectile dysfunction nasal spray treatment in advanced development, LTR Pharma is already creating serious buzz. Ahead of its ASX listing next week, [more…]
